ZAVANTE Trademark

Trademark Overview

On Thursday, February 6, 2014, a trademark application was filed for ZAVANTE with the United States Patent and Trademark Office. The USPTO has given the ZAVANTE trademark a serial number of 86185905. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 8, 2021. This trademark is owned by Zavante Therapeutics, Inc. The ZAVANTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
zavante

General Information

Serial Number86185905
Word MarkZAVANTE
Filing DateThursday, February 6, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 8, 2021
Registration Number4697125
Registration DateTuesday, March 3, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 24, 2014

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 8, 2021
Primary Code042
First Use Anywhere DateTuesday, May 14, 2013
First Use In Commerce DateWednesday, March 12, 2014

Trademark Owner History

Party NameZavante Therapeutics, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 921211025
Party NameZavante Therapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarietta, GA 30066
Party NameZavante Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarietta, GA 30066

Trademark Events

Event DateEvent Description
Wednesday, July 19, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, October 8, 2021CANCELLED SEC. 8 (6-YR)
Monday, January 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 24, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 24, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 24, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 3, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, February 20, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 31, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 31, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 31, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 31, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 3, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, January 29, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 28, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 22, 2015STATEMENT OF USE PROCESSING COMPLETE
Friday, December 5, 2014USE AMENDMENT FILED
Wednesday, January 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 5, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, August 19, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 24, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 24, 2014PUBLISHED FOR OPPOSITION
Wednesday, June 4, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 14, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 14, 2014ASSIGNED TO EXAMINER
Wednesday, February 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 10, 2014NEW APPLICATION ENTERED

Related Keywords

zavante pharmaceuticals clinical trials field information medical scientific research providing